Wockhardt drug approvals delayed
Wockhardt Ltd., maker of insulin and hepatitis vaccines, will not win new drug approvals this year for about half the […]
Corporate updates
Wockhardt too a part of FDA toxic capsule
Ltd is the first Indian company thats said it faces FDA strictures since Ranbaxy made details of its case public […]
Funding boost for GSK’s open innovation research into diseases affecting the developing world
GlaxoSmithKline plc (GSK) announced a funding injection of up to £5m from the Wellcome Trust to support its open approach […]
Mumbais Jaslok Hospital opts for Napier EHRm solution
Napier Healthcare Solutions, a leading healthcare software provider, announced that Jaslok Hospital of Mumbai has selected the Napier EHRm management […]
Daburs domestic volume growth is in good health
Dabur India Ltds March quarter results did not excite investors despite a smart recovery in domestic volume growth. Net sales […]
Abbott India Q1 net up 17% at Rs 31.70 cr
Drug firm Abbott India aid its net profit rose by 17.06 per cent to Rs 31.70 crore for the first […]
Fortis Healthcare to raise $100 million from World Bank arm
India’s largest hospital chain Fortis Healthcare will raise $100 million ( 540 crore) from International Finance Corporation ( IFC). Washington, […]
Cipla’s petition against drug price revision rejected
The Department of Pharmaceuticals (DoP) turned down a review petition by drug maker Cipla against a price fixation order by […]
VC Funding in Healthcare IT Sector Continues Torrid Pace in Q1 2013 with $493 Million,
VC Funding in Healthcare IT Sector Continues Torrid Pace in Q1 2013 with $493 Million, Reports […]
Pfizer reduces its staff base in India
Pharma giant Pfizer is alleged cutting down its work force in India by insisting they retire voluntarily. The company has […]
Dabur’s PE firm AHF to invest in dental chain
Asian Healthcare Fund, a private equity firm floated by DaburBSE -0.58 % Group chairman Anand Burman and former Dabur Pharma […]
GlaxoSmithkline Consumer Healthcare Chairman Simon Scarff to quit
GlaxoSmithkline Consumer Healthcare’s Simon Scarff will step down as chairman effective April 30, 2013. Scarff’s expressed the desire during the […]
Price of cancer drugs to fall
Cancer drugs will cost almost 25% less if a new formula that calls for a price cap is implemented. The […]
-
-
Delhi to host forum on homoeopathic medicine
22-02-2017
